BBG Advanced Therapies (BBGAT), a subsidiary of BioBridge Global and [...]

Vitalant has launched a national hub-and-spoke model to expand patient [...]

NanoPhoria Bioscience has completed an €83.5 million Series A financing [...]

AAVantgarde Bio has received two regulatory milestones for its investigational [...]

CTMC, a joint venture between Resilience and MD Anderson Cancer [...]

EG 427 has released encouraging first clinical data from its [...]

Xeltis’ aXess EU key trial shows sustained patency, fewer interventions, [...]

Levicept Ltd will present new findings from its Phase 2 [...]

Tevard Biosciences has presented new preclinical data demonstrating the potential [...]

PACE (Pathways to Antimicrobial Clinical Efficacy) has launched its third [...]